Radiosensitization of endometrial adenocarcinoma by means of medroxyprogesterone.
D000230:Adenocarcinoma / Q000532:radiotherapy*; D000328:Adult; D005260:Female; D006801:Humans; D008525:Medroxyprogesterone / Q000627:therapeutic use*; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D011879:Radiotherapy Dosage; D011883:Radium / Q000627:therapeutic use*; D014594:Uterine Neoplasms / Q000532:radiotherapy*
D011838:Radiation-Sensitizing Agents; D008525:Medroxyprogesterone; D011883:Radium